Cristian Rodriguez-Aguayo
Overview
Explore the profile of Cristian Rodriguez-Aguayo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
137
Citations
5527
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bueno-Rojas D, Bueno-Rojas J, Rodriguez-Aguayo C, Calderon-Santoyo M, Zamora-Gasga V, Montalvo-Gonzalez E, et al.
Food Chem
. 2024 Dec;
469():142348.
PMID: 39729659
Kombucha is a fermented beverage with health effects, made mainly from green tea and black tea; however, it can also be made from other leaves such as those of jackfruit...
2.
Kanlikilicer P, Bayraktar R, Denizli M, Rashed M, Ivan C, Aslan B, et al.
EBioMedicine
. 2024 Dec;
111():105486.
PMID: 39637523
No abstract available.
3.
Cakan E, Lara O, Szymanowska A, Bayraktar E, Chavez-Reyes A, Lopez-Berestein G, et al.
Cancers (Basel)
. 2024 Sep;
16(17).
PMID: 39272802
Advancements in our comprehension of tumor biology and chemoresistance have spurred the development of treatments that precisely target specific molecules within the body. Despite the expanding landscape of therapeutic options,...
4.
Czopik A, McNamee E, Vaughn V, Huang X, Bang I, Clark T, et al.
Nat Commun
. 2024 Sep;
15(1):8042.
PMID: 39271652
Metabolic imbalance leading to inflammatory hypoxia and stabilization of hypoxia-inducible transcription factors (HIFs) is a hallmark of inflammatory bowel diseases. We hypothesize that HIF could be stabilized in CD4 T...
5.
Corvigno S, Liu Y, Bayraktar E, Stur E, Bayram N, Lankenau Ahumada A, et al.
NPJ Precis Oncol
. 2024 Apr;
8(1):86.
PMID: 38582949
Small RNAs (microRNAs [miRNAs] or small interfering RNAs [siRNAs]) are effective tools for cancer therapy, but many of the existing carriers for their delivery are limited by low bioavailability, insufficient...
6.
Chakraborty D, Gutierrez-Chakraborty E, Rodriguez-Aguayo C, Basagaoglu H, Lopez-Berestein G, Amero P
Cancer Commun (Lond)
. 2024 Apr;
44(5):584-588.
PMID: 38566430
No abstract available.
7.
Joseph R, Dasari S, Umamaheswaran S, Mangala L, Bayraktar E, Rodriguez-Aguayo C, et al.
Int J Mol Sci
. 2024 Jan;
25(2).
PMID: 38279277
Endometrial cancer is the most frequent malignant tumor of the female reproductive tract but lacks effective therapy. EphA2, a receptor tyrosine kinase, is overexpressed by various cancers including endometrial cancer...
8.
Martinez-Castillo M, Elsayed A, Lopez-Berestein G, Amero P, Rodriguez-Aguayo C
Noncoding RNA
. 2023 Nov;
9(6).
PMID: 37987366
Long non-coding RNAs (lncRNAs) play pivotal roles in regulating immune responses, immune cell differentiation, activation, and inflammatory processes. In cancer, they are gaining prominence as potential therapeutic targets due to...
9.
Szymanowski W, Szymanowska A, Bielawska A, Lopez-Berestein G, Rodriguez-Aguayo C, Amero P
Cancers (Basel)
. 2023 Nov;
15(21).
PMID: 37958473
Ovarian cancer (OC) is the most common lethal gynecologic cause of death in women worldwide, with a high mortality rate and increasing incidence. Despite advancements in the treatment, most OC...
10.
Rodriguez-Aguayo C, Del C Monroig P, Redis R, Bayraktar E, Almeida M, Ivan C, et al.
Cell Discov
. 2023 Nov;
9(1):111.
PMID: 37940695
No abstract available.